Published in
Centers for Disease Control and Prevention, Emerging Infectious Diseases, 5(21), p. 847-851, 2015
Links
- Centers for Disease Control and Prevention
- ORCID
- [www.ncbi.nlm.nih.gov] | PDF
- [europepmc.org] | PDF
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [researchonline.lshtm.ac.uk] | PDF
Tools
Antimicrobial Drug Resistance ofVibrio cholerae, Democratic Republic of the Congo
Journal article published in 2015 by
Berthe Miwanda,
Sandra Moore,
Jean-Jacques Muyembe,
Georges Nguefack-Tsague 
,
Ickel Kakongo Kabangwa,
Daniel Yassa Ndjakani,
Ankur Mutreja,
Nicholas Thomson,
Helene Thefenne,
Eric Garnotel,
Gaston Tshapenda,
Denis Kandolo Kakongo,
Guy Kalambayi,
Renaud Piarroux
,
Ickel Kakongo Kabangwa,
Daniel Yassa Ndjakani,
Ankur Mutreja,
Nicholas Thomson,
Helene Thefenne,
Eric Garnotel,
Gaston Tshapenda,
Denis Kandolo Kakongo,
Guy Kalambayi,
Renaud Piarroux
This paper is made freely available by the publisher.
Full text: Download
Data provided by 
Abstract
We analyzed 1,093 Vibrio cholerae isolates from the Democratic Republic of the Congo during 1997–2012 and found increasing antimicrobial drug resistance over time. Our study also demonstrated that the 2011–2012 epidemic was caused by an El Tor variant clonal complex with a single antimicrobial drug susceptibility profile.